We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Ingested Dual Balloon Encourages Weight Loss

By HospiMedica International staff writers
Posted on 12 Aug 2015
A novel non-surgical weight loss procedure aids people who either do not want or do not qualify for bariatric surgery.

The ReShape Integrated Dual Balloon System consists of two connected balloons that occupy space in the stomach, so that patients feel satiety with smaller portions of food. More...
The system is inserted via an endoscopic procedure; once in place, the two balloons are inflated using saline, and remain in the stomach for six months to help reduce hunger. During these first six months, and for the six months after the balloons are removed, patients receive comprehensive counseling and support services that include frequent in-office coaching sessions.

The ReShape provides a personalized pathway broken down into three phases over the 12 months. The first phase involves a personalized evaluation and education session. The two balloons are then inserted in the stomach in a 20 minute procedure. This is followed by personalized coaching, with a focus on healthy eating, exercise, and lifestyle habits, to maximize treatment success. The balloons are removed at six months, with six monthly sessions continuing onwards thereafter to set goals and track progress.

To help patients monitor their progress, a ReShape Patient Portal provides weight logging, food logging, activity tracking, goal setting, articles and recipes, community forums, and other important reminders. The portal can be accessed from a smartphone or tablet, and the Fitbit (San Francisco, CA, USA) wireless scale and activity tracker can be integrated as well to integrate all weight loss data in one place.

The ReShape Integrated Dual Balloon System is a product of ReShape Medical (San Clemente, CA, USA), and has been approved by the US Food and Drug Administration (FDA). It is indicated for weight reduction when used in conjunction with diet and exercise, in obese patients with a body mass index (BMI) of 30–40 kg/m2, one or more obesity-related comorbidity conditions, and who have failed weight reduction with diet and exercise alone.

“Many Americans have struggled with a lack of effective weight loss options when their BMI is in the 30–40 range,” said John Morton, MD, MPH, president of the American Society for Metabolic and Bariatric Surgery (Gainesville, FL, USA). “Options like ReShape address a significant gap that exists between diet and exercise, weight loss medications and surgery, offering a minimally invasive, reversible option which we hope will promote long-term healthy habits.”

Related Links:

ReShape Medical
Fitbit
American Society for Metabolic and Bariatric Surgery



Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Glucose Meter
StatStrip®
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Brain PET imaging could help identify Alzheimer’s patients most likely to benefit from available therapies (Image Credit: iStock)

Amyloid and Tau PET Guide Selection and Monitoring of Alzheimer’s Therapy

Alzheimer’s disease is the most common form of dementia and can be difficult to distinguish from other causes of cognitive decline. According to the World Health Organization (WHO), 57 million people were... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.